Charming Medical Limited (MCTA) Return on equity 2025–2026
Charming Medical Limited (MCTA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.4%FY2026 · since FY2025: 2435.0% → -0.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -0.4% | -2435.5 pp |
| FY2025 | 2435.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MCTA financial trends
MCTA RevenueMCTA Net incomeMCTA Net marginMCTA Gross profitMCTA Gross marginMCTA Operating incomeMCTA Operating marginMCTA Operating cash flowMCTA Free cash flowMCTA Capital expendituresMCTA Stock buybacksMCTA Dividends paidMCTA Total assetsMCTA Total liabilitiesMCTA Shareholders’ equityMCTA overview →